Bausch Health Co. Inc. (BHC) Tops Q4 EPS by 2c; offers guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $2.56 billion versus the consensus estimate of $2.52 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2025 revenue of $9.9-10.150 billion, versus the consensus of $10.342 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• InMed Pharmaceuticals gets Nasdaq equity deficiency notice
• SmartKem (SMTK) files for 15.13M share offering by selling stockholders